Purple Biotech Stock Price History

PPBT Stock  USD 3.36  0.11  3.38%   
Below is the normalized historical share price chart for Purple Biotech extending back to November 20, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Purple Biotech stands at 3.36, as last reported on the 2nd of December, with the highest price reaching 3.48 and the lowest price hitting 3.25 during the day.
IPO Date
20th of November 2015
200 Day MA
9.028
50 Day MA
3.9135
Beta
0.384
 
Yuan Drop
 
Covid
If you're considering investing in Purple Stock, it is important to understand the factors that can impact its price. Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.18, which implies the firm had a -0.18% return per unit of risk over the last 3 months. Purple Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Coefficient Of Variation of (657.33), risk adjusted performance of (0.11), and Variance of 57.2 to confirm the risk estimate we provide.
  
Common Stock Shares Outstanding is likely to gain to about 232.4 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 27.6 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 42.43 in 2024, whereas Price To Sales Ratio is likely to drop 84.89 in 2024. Purple Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1765

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsPPBT

Estimated Market Risk

 7.57
  actual daily
67
67% of assets are less volatile

Expected Return

 -1.34
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.18
  actual daily
0
Most of other assets perform better
Based on monthly moving average Purple Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Purple Biotech by adding Purple Biotech to a well-diversified portfolio.
Price Book
0.1786
Enterprise Value Ebitda
(0.15)
Price Sales
58.0756
Shares Float
244 M
Wall Street Target Price
33

Purple Biotech Stock Price History Chart

There are several ways to analyze Purple Stock price data. The simplest method is using a basic Purple candlestick price chart, which shows Purple Biotech price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceSeptember 6, 20249.01
Lowest PriceNovember 22, 20242.19

Purple Biotech December 2, 2024 Stock Price Synopsis

Various analyses of Purple Biotech's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Purple Stock. It can be used to describe the percentage change in the price of Purple Biotech from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Purple Stock.
Purple Biotech Price Action Indicator 0.05 
Purple Biotech Price Daily Balance Of Power 0.48 
Purple Biotech Price Rate Of Daily Change 1.03 

Purple Biotech December 2, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Purple Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Purple Biotech intraday prices and daily technical indicators to check the level of noise trading in Purple Stock and then apply it to test your longer-term investment strategies against Purple.

Purple Stock Price History Data

The price series of Purple Biotech for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 has a statistical range of 7.59 with a coefficient of variation of 44.33. The price distribution for the period has arithmetic mean of 4.97. The median price for the last 90 days is 4.37. The company completed stock split (1:20) on 17th of September 2024. Purple Biotech had dividends distributed to its stock-holders on 2020-08-21.
OpenHighLowCloseVolume
12/02/2024
 3.25  3.48  3.25  3.36 
11/29/2024 3.25  3.48  3.25  3.36  38,166 
11/27/2024 2.73  3.65  2.56  3.25  209,759 
11/26/2024 2.57  2.82  2.57  2.64  42,397 
11/25/2024 2.43  2.80  2.35  2.74  64,773 
11/22/2024 2.48  2.65  2.00  2.19  113,853 
11/21/2024 2.51  2.61  2.42  2.54  25,695 
11/20/2024 2.58  2.78  2.40  2.47  62,511 
11/19/2024 2.80  2.80  2.47  2.62  132,649 
11/18/2024 2.52  2.55  2.42  2.55  13,721 
11/15/2024 2.51  2.69  2.41  2.51  33,330 
11/14/2024 2.75  2.75  2.50  2.52  22,394 
11/13/2024 2.82  2.82  2.55  2.66  44,630 
11/12/2024 2.71  2.80  2.50  2.80  22,072 
11/11/2024 2.76  2.90  2.57  2.58  44,645 
11/08/2024 2.95  3.14  2.60  2.81  71,069 
11/07/2024 2.78  2.95  2.73  2.82  37,622 
11/06/2024 3.00  3.09  2.72  2.78  43,437 
11/05/2024 3.06  3.20  2.65  2.88  37,171 
11/04/2024 3.20  3.35  2.84  2.97  315,332 
11/01/2024 3.20  3.42  3.00  3.11  22,212 
10/31/2024 3.35  3.35  3.11  3.21  16,015 
10/30/2024 3.40  3.56  3.20  3.30  51,108 
10/29/2024 3.26  3.90  3.20  3.48  170,158 
10/28/2024 4.21  4.21  3.00  3.07  115,036 
10/25/2024 4.69  4.69  4.05  4.10  41,340 
10/24/2024 5.00  5.04  4.50  4.52  40,963 
10/23/2024 4.77  4.97  4.50  4.80  37,201 
10/22/2024 4.40  4.85  4.27  4.50  20,300 
10/21/2024 4.29  4.57  3.85  4.49  55,761 
10/18/2024 4.18  4.54  4.11  4.37  30,335 
10/17/2024 4.15  4.19  4.08  4.18  3,125 
10/16/2024 4.09  4.23  4.03  4.10  17,347 
10/15/2024 4.10  4.17  3.95  4.14  8,725 
10/14/2024 4.06  4.11  4.00  4.10  4,263 
10/11/2024 4.07  4.36  4.05  4.20  12,128 
10/10/2024 4.18  4.29  3.89  4.04  20,208 
10/09/2024 4.25  4.39  3.82  4.17  38,043 
10/08/2024 4.78  4.86  3.76  4.13  123,223 
10/07/2024 4.92  5.23  4.42  4.81  98,464 
10/04/2024 5.45  5.48  4.73  4.97  40,854 
10/03/2024 5.90  5.92  5.37  5.40  49,617 
10/02/2024 5.81  5.89  5.76  5.88  12,434 
10/01/2024 5.53  5.83  5.20  5.77  51,872 
09/30/2024 5.40  5.67  5.32  5.55  20,388 
09/27/2024 5.27  5.54  5.18  5.42  14,510 
09/26/2024 5.77  5.85  5.13  5.17  50,012 
09/25/2024 6.09  6.47  5.49  5.65  93,189 
09/24/2024 6.50  6.72  5.30  6.00  120,605 
09/23/2024 6.71  6.89  6.26  6.49  48,824 
09/20/2024 7.03  7.03  6.68  6.89  13,805 
09/19/2024 7.15  7.20  6.60  6.98  30,686 
09/18/2024 7.50  7.82  6.86  7.10  68,848 
09/17/2024 7.83  7.83  6.51  7.37  82,169 
09/16/2024 8.00  8.60  7.44  8.02  24,126 
09/13/2024 7.69  8.30  7.11  7.74  50,372 
09/12/2024 7.36  7.70  7.04  7.20  14,866 
09/11/2024 8.30  8.30  7.50  7.60  16,114 
09/10/2024 7.87  8.46  7.87  8.17  2,786 
09/09/2024 9.30  9.40  7.86  8.11  17,545 
09/06/2024 9.10  9.49  8.70  9.01  4,596 

About Purple Biotech Stock history

Purple Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Purple is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Purple Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Purple Biotech stock prices may prove useful in developing a viable investing in Purple Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding221.3 M232.4 M
Net Loss-19.5 M-20.5 M

Purple Biotech Quarterly Net Working Capital

1.4 Million

Purple Biotech Stock Technical Analysis

Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Purple Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Purple Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run My Watchlist Analysis Now

   

My Watchlist Analysis

Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
All  Next Launch Module

Purple Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Purple Biotech's price direction in advance. Along with the technical and fundamental analysis of Purple Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Purple to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Purple Stock Analysis

When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.